Authors: HAJNZIC TF KASTELAN M KOLARIC K HAJNIC T CVITANOVICSOJAT L

Citation: Tf. Hajnzic et al., CELLULAR-IMMUNITY IN IMMUNOCOMPROMISED CHILDREN WITH BRAIN-TUMOR (BT)TREATED BY LEVAMISOLE (LE), Annals of oncology, 9, 1998, pp. 716-716

Authors: ROTH A KOLARIC K ZUPANC D

Citation: A. Roth et al., HIGH-DOSES OF EPIRUBICIN AND 5-FLUOROURACIL WITH OR WITHOUT CISPLATININ ADVANCED GASTRIC-CANCER, European journal of cancer, 31A, 1995, pp. 562-562

Authors: KOLARIC K BRADAMANTE V CERVEK J CIESLINSKA A CISARZFILIPCAK E DENISOV LE DONAT D DROSIK K GERSHANOVIC M HUDZIEC P JELIC S JURGA L KALASIEWICZ M KOWGIRD L KOZACKA M LICHINITZER M MACHALSKI M MECHL Z ODINTSOV S PAWLICKI M RUBACH D ROTH A STABUC B TOMCZAK J UTRACKA B ZBORZIL J ROGAN J

Citation: K. Kolaric et al., A PHASE-II TRIAL OF CARDIOPROTECTION WITH CARDIOXANE (ICRF-187) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE, Oncology, 52(3), 1995, pp. 251-255

Authors: RUDAN I RUDAN N STRNAD M KOLARIC K

Citation: I. Rudan et al., THE CAUSES OF BREAST-CANCER INCIDENCE GROWTH IN CROATIA .1., Collegium antropologicum, 18(2), 1994, pp. 291-299